Diagnosed with malignant cancer, Bu Anis shares her experience: “If you want to quickly be free from cancer, have minimal surgery to remove the large tumor mass, then use ECCT to clean up the rest.” With this approach, remission can usually be achieved relatively quickly – 1-3 months for high-grade malignancies, and 3-6 months for moderate malignancies, without the need for a full mastectomy or chemotherapy.
In June 2013, the results of Bu Anis’ lumpectomy to remove a lump in her right breast showed malignancy: Invasive Ductal Carcinoma, Grade 2. The tumor mass removed was about 2.5 x 1 cm in size. In addition to the tumor that had invaded surrounding tissue, there were also tumor cells that had not yet broken out of the protective membrane, known as DCIS (Ductal Carcinoma In Situ). These DCIS cells formed small cysts that appeared around the skin near the nipple.
Based on the pathology results, her doctor recommended a full mastectomy, possibly followed by chemotherapy or radiation depending on the immunohistochemistry (IHC) results. However, Bu Anis did not want a full mastectomy on her right breast. Was there no other alternative to surgery and chemo?
After searching with her husband for all possible alternatives, including herbal options, Bu Anis eventually chose ECCT. At the time, ECCT was still very new and highly controversial in the medical world because it offered an alternative cancer treatment without surgery.
Bu Anis was convinced by the ECCT option after reading about the case of Bu Suwarni, the first person to use the ECCT device. Bu Suwarni had undergone full mastectomy on her left breast and had several large lumps (>3 cm) removed from her armpit. However, she did not undergo chemotherapy and instead used the ECCT device. Bu Anis thought that since her tumor had been removed with a lumpectomy, it would be easier to clean up the remaining cancer cells using the device alone, without additional major surgery or chemotherapy, like Bu Suwarni did.
Bu Anis’ reasoning proved to be sound. Since the large tumor had been removed, and only small lumps remained in the axillary region and possibly some residual cancer in the breast, using the ECCT device caused no major issues. The detox reactions she experienced only lasted a few days. After two years of using the device, Bu Anis underwent a PET scan, which showed that she was CLEAR.
Bu Anis’ case was actually considered a slow response to ECCT due to her moderate malignancy level (Grade 2), categorized as Type D in response classification. ECCT generally responds faster to cancers with high malignancy levels (Grade 3 or higher), like in Bu Suwarni’s case. Bu Suwarni achieved remission in just one month, confirmed in the following month. For Grade 3 post-surgery cases, it typically takes 1-3 months to clear any remaining active cells with ECCT, even if the cancer has spread to the armpit and possibly other organs (Stage 4), as it did for Bu Suwarni.
In Bu Anis’ Grade 2 case, the slower response to the device was due to the slower growth rate of the cancer cells, as well as the presence of a higher lipid (cholesterol) content in the tumor. This led to a slower detox process. The accumulation of fat-laden dead cells near the original tumor site slowed down the subsequent therapy.
It took Bu Anis two years to achieve remission, compared to 1-2 months for Bu Suwarni. Therefore, for lower-grade malignancies like Bu Anis’ case, minimal surgery is recommended, such as removing large masses/lumps (e.g., BCT or lumpectomy), and the remaining cells can be cleaned up with ECCT.
Bu Anis continues to use the ECCT device to this day for preventive care and general health, as one of the other positive effects of ECCT is improving blood circulation. Wishing Bu Anis continued health (WS).